Specialty pharmaceutical company Encube Ethicals has filed preliminary documents with the Securities and Exchange Board of India (SEBI) for an initial public offering valued at ₹3,000 crore.
The Mumbai-based firm’s move marks its debut on public markets, aiming to provide liquidity for existing shareholders and raise capital for future growth.
The filing adds to a busy period for Indian equity markets, where several mid-cap firms are seeking public listings.
Encube Ethicals follows in the footsteps of Ratnadeep Retail, which filed for a ₹400 crore IPO earlier this month to fund expansion and debt repayment. The broader trend includes recent approvals for Torrent Gas, Sathya Agencies, and Kanohar Electricals, signaling sustained investor appetite for new issues in the Indian market.
Encube Ethicals operates in the specialty pharmaceuticals sector, a space that has seen increased consolidation and public market activity in recent years.
The company’s decision to go public comes as Indian regulators continue to streamline the IPO process, making it more attractive for private firms to access public capital.
The ₹3,000 crore valuation places Encube among the larger recent filings, reflecting confidence in the company’s growth trajectory and market position.